- Home
- STAA vs BXMX Comparison
STAA vs BXMX Comparison
Compare STAA & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- BXMX
- Stock Information
- Founded
- STAA 1982
- BXMX 2004
- Country
- STAA United States
- BXMX United States
- Employees
- STAA N/A
- BXMX N/A
- Industry
- STAA Ophthalmic Goods
- BXMX Investment Managers
- Sector
- STAA Health Care
- BXMX Finance
- Exchange
- STAA Nasdaq
- BXMX Nasdaq
- Market Cap
- STAA 1.4B
- BXMX 1.5B
- IPO Year
- STAA N/A
- BXMX N/A
- Fundamental
- Price
- STAA $26.50
- BXMX $14.37
- Analyst Decision
- STAA Hold
- BXMX
- Analyst Count
- STAA 8
- BXMX 0
- Target Price
- STAA $22.50
- BXMX N/A
- AVG Volume (30 Days)
- STAA 815.1K
- BXMX 205.6K
- Earning Date
- STAA 10-29-2025
- BXMX 01-01-0001
- Dividend Yield
- STAA N/A
- BXMX 7.24%
- EPS Growth
- STAA N/A
- BXMX N/A
- EPS
- STAA N/A
- BXMX N/A
- Revenue
- STAA $224,449,000.00
- BXMX N/A
- Revenue This Year
- STAA N/A
- BXMX N/A
- Revenue Next Year
- STAA $27.24
- BXMX N/A
- P/E Ratio
- STAA N/A
- BXMX N/A
- Revenue Growth
- STAA N/A
- BXMX N/A
- 52 Week Low
- STAA $13.50
- BXMX $11.75
- 52 Week High
- STAA $35.39
- BXMX $13.75
- Technical
- Relative Strength Index (RSI)
- STAA 46.84
- BXMX 55.67
- Support Level
- STAA $26.10
- BXMX $14.25
- Resistance Level
- STAA $27.49
- BXMX $14.47
- Average True Range (ATR)
- STAA 0.41
- BXMX 0.11
- MACD
- STAA -0.15
- BXMX -0.00
- Stochastic Oscillator
- STAA 35.97
- BXMX 61.38
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.